Hazte socio de la SAMFyC

Última publicación SAMFyC: Actualización en MF y APS

 

AULA VIRTUAL SAMFyC

Aula de formación virtual de SAMFyC

SAMFyC CONGRESOS

Historico de Comunicaciones
presentadas a los Congresos
Andaluces de MFyC (SAMFyC), desde 2008.


* * * * * * * * * * * * * * * * * * * * * * * * *

Información Socios

Ofertas de Trabajo
Ofertas de Trabajo SOCIOS SAMFYC

¡Actualiza tus datos!
Actualiza tus datos

 

Buscador de Contenidos

Sociedades Federadas

Medicina Familiar y Comunitaria

Sociedades Científicas de Medicina Familiar y Comunitaria

Enlaces de Interés

Consulte Nuestros Enlaces.
Enlaces de Interés

Acceso Socios



Buscador de publicaciones externas y alertas bibliográficas

Mayo 2012 PDF Imprimir E-mail
Escrito por Administrador General de SAMFyC   
Martes, 05 de Junio de 2012 00:00

SELECCIÓN DE REFERENCIAS BIBLIOGRÁFICAS DE LO PUBLICADO EN RELACIÓN CON LA ATENCIÓN PRIMARIA

Selección realizada por Antonio Manteca González

 

ACADEMIC MEDICINE
_______________________________________________________

 

Hunt D, Migdal M, Eaglen R, Barzansky B, Sabalis R. The unintended consequences of clarity: reviewing the actions of the Liaison Committee on Medical Education before and after the reformatting of accreditation standards. Acad Med. 2012; 87: 560-566 [QE,I]

22450183             RESUMEN/CONCLUSIONES

CONSECUENCIAS NO BUSCADAS DE LA TRANSPARENCIA: REVISAR LAS ACCIONES DEL COMITÉ DE COORDINACIÓN PARA LA FORMACIÓN MÉDICA ANTES Y DESPUÉS DEL CAMBIO DE FORMATO DE LAS NORMAS DE ACREDITACIÓN

 

Wittich CM, Chutka DS, Mauck KF, Berger RA, Litin SC, Beckman TJ. Perspective: a practical approach to defining professional practice gaps for continuing medical education. Acad Med. 2012; 87: 582-585 [R,II]

22450184             R/C                        

PERSPECTIVA: ABORDAJE PRÁCTICO A LA DEFINICIÓN DE LAGUNAS DE PRÁCTICA PROFESIONAL PARA LA FORMACIÓN MÉDICA CONTINUADA

 

ANNALS OF INTERNAL MEDICINE

 

Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, et al. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012; 156: 609-617 [T,II]

22547470             R/C

INCLINAR LA BALANZA DE BENEFICIOS Y PERJUICIOS A FAVOR DEL CRIBAJE MAMOGRÁFICO EMPEZANDO A LOS 40 AÑOS: ESTUDIO DE MODELAJE COMPARATIVO DE RIESGOS

 

 De Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, et al. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med. 2012; 156: 627-634 [S,I]

22547472             R/C

CONCENTRACIÓN SÉRICA DE 25-HIDROXIVITAMINA D Y RIESGO DE ENFERMEDADES IMPORTANTES EN UNA POBLACIÓN DE ANCIANOS EN LA COMUNIDAD: ESTUDIO DE COHORTES

 

Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012; 156: 635-648 [M,II]

22547473             R/C

FACTORES DE RIESGO DE CÁNCER DE MAMA EN MUJERES ENTRE 40 Y 49 AÑOS: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Brooks RC, Hasley PB, Jasti H, Macpherson D. Update in general internal medicine: evidence published in 2011. Ann Intern Med. 2012; 156: 649-653 [R,I]

22517813

ACTUALIZACIÓN EN MEDICINA INTERNA GENERAL: EVIDENCIAS PUBLICADAS EN 2011

 

Brawley OW. Risk-based mammography screening: an effort to maximize the benefits and minimize the harms. Ann Intern Med. 2012; 156: 662-663 [AO,I]

22547477

CRIBAJE MAMOGRÁFICO BASADO EN EL RIESGO: ESFUERZO PARA MAXIMIZAR LOS BENEFICIOS Y MINIMIZAR LOS PERJUICIOS

 

Fan VS, Gaziano JM, Lew R, Bourbeau J, Adams SG, Leatherman S, et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med. 2012; 156: 673-683 [EC,I]

22586006             R/C

PROGRAMA DE GESTIÓN ASISTENCIAL INTEGRAL PARA PREVENIR LAS HOSPITALIZACIONES POR EPOC: ENSAYO CONTROLADO ALEATORIZADO

 

Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med. 2012; 156: 703-709 [M,II]

22586009             R/C

RIESGO DE CÁNCER COLORRECTAL EN PERSONAS CON HISTORIA FAMILIAR DE PÓLIPOS ADENOMATOSOS: REVISIÓN SISTEMÁTICA

Neumann I, Rada G, Claro JC, Carrasco-Labra A, Thorlund K, Akl EA, et al. Oral direct factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Ann Intern Med. 2012; 156: 710-719 [M,II]

22412038             R/C

INHIBIDORES ORALES DEL FACTOR DIRECTO Xa FRENTE A HBPM PARA PREVENIR EL TROMBOEMBOLISMO VENOSO EN PACIENTES QUE SE SOMETEN A SUSTITUCIÓN TOTAL DE CADERA O RODILLA: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

ARCHIVES OF INTERNAL MEDICINE

 

Kwak SM, Myung SK, Lee YJ, Seo HG; for the Korean Meta-analysis Study Group. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012 [Epub ahead of print] [M,II]

22493407             R/C

EFICACIA DE LOS SUPLEMENTOS DE ÁCIDOS GRASOS OMEGA-3 (ÁCIDO EICOSAPENTANOICO Y ÁCIDO DOCOSAHEXANOICO) EN LA PREVENCIÓN SECUNDARIA DE LA ENFERMEDAD CARDIOVASCULAR: METAANÁLISIS DE ENSAYOS CONTROLADOS CON PLACEBO, ALEATORIZADOS Y A DOBLE CIEGO

 

Hu FB, Manson JE. Omega-3 fatty acids and secondary prevention of cardiovascular disease--is it just a fish tale?: comment on "Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease". Arch Intern Med. 2012  [Epub ahead of print] [AO,I]

22493410

LOS ÁCIDOS GRASOS OMEGA 3 Y LA PREVENCIÓN SECUNDARIA DE LA ENFERMEDAD CARDIOVASCULAR  ¿ES SÓLO UN CUENTO DE PESCADO?*: COMENTARIO SOBRE " EFICACIA DE LOS SUPLEMENTOS DE ÁCIDOS GRASOS OMEGA-3 (ÁCIDO EICOSAPENTANOICO Y ÁCIDO DOCOSAHEXANOICO) EN LA PREVENCIÓN SECUNDARIA DE LA ENFERMEDAD CARDIOVASCULAR"

*Juego de palabras con la homofonía de fish tale y fishtail (cola de pescado)

 

ARCHIVOS DE BRONCONEUMOLOGIA

 

Puente L, García J. Las pruebas funcionales respiratorias en las decisiones clínicas. Arch Bronconeumol. 2012; 48: 161-169 [R,I]

22364671             R/C

LAS PRUEBAS FUNCIONALES RESPIRATORIAS EN LAS DECISIONES CLÍNICAS

ARTHRITIS AND RHEUMATISM

 

Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH. The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. Arthritis Rheum. 2012; 64: 1407-1411 [T,I]

22139851             R/C

PREVALENCIA DE HLA-B27 EN LOS EE UU: DATOS DE LA ENCUESTA US NATIONAL HEALTH AND NUTRITION EXAMINATION

 

Wittoek R, Cruyssen BV, Verbruggen G. Predictors of functional impairment and pain in erosive osteoarthritis of the interphalangeal joints: comparison with controlled inflammatory arthritis. Arthritis Rheum. 2012; 64: 1430-1436 [T,I]

22139828             R/C

PREDICTORES DE ALTERACIÓN FUNCIONAL Y DOLOR EN LA ARTROSIS EROSIVA DE LAS ARTICULACIONES INTERFALÁNGICAS: COMPARACIÓN CON LA ARTRITIS INFLAMATORIA CONTROLADA

 

Muraki S, Akune T, Oka H, Ishimoto Y, Nagata K, Yoshida M, et al. Incidence and risk factors for radiographic knee osteoarthritis and knee pain in Japanese men and women: a longitudinal population-based cohort study. Arthritis Rheum. 2012; 64: 1447-1456 [S,I]

22135156             R/C

INCIDENCIA Y FACTORES DE RIESGO DE ARTROSIS DE RODILLA RADIOGRÁFICA Y DOLOR DE RODILLA EN HOMBRES Y MUJERES JAPONESES: ESTUDIO DE COHORTES POBLACIONAL LONGITUDINAL

 

Samartzis D, Karppinen J, Chan D, Luk KD, Cheung KM. The association of lumbar intervertebral disc degeneration on magnetic resonance imaging with body mass index in overweight and obese adults: a population-based study. Arthritis Rheum. 2012; 64: 1488-1496 [T,I]

22287295             R/C

ASOCIACIÓN DE LA DEGENERACIÓN DISCAL INTERVERTEBRAL LUMBAR POR IMAGEN DE RESONANCIA MAGNÉTICA CON EL ÍNDICE DE MASA CORPORAL EN ADULTOS OBESOS Y CON SOBREPESO: ESTUDIO POBLACIONAL

 

ATENCION PRIMARIA

 

Hernández MÁ, Palacio F. La prescripción y los Doce Trabajos de Heracles: más allá del principio activo. Aten Primaria. 2012; 44: 245-247 [AO,I]

22546290

LA PRESCRIPCIÓN Y LOS DOCE TRABAJOS DE HERACLES: MÁS ALLÁ DEL PRINCIPIO ACTIVO

 

Segura A. La dimensión social y cultural de la prevención. Aten Primaria. 2012; 44: 248-249 [AO,I]

22464294

LA DIMENSIÓN SOCIAL Y CULTURAL DE LA PREVENCIÓN

 

Mateos ML, Vián EM, Gil M, Lozano JE, Santamaría E, Herrero B. Incidencia, características epidemiológicas y tipos de accidentes domésticos y de ocio. Red centinela sanitaria de Castilla y León (2009) Aten Primaria. 2012; 44: 250-256 [T,I]

21733598             R/C

INCIDENCIA, CARACTERÍSTICAS EPIDEMIOLÓGICAS Y TIPOS DE ACCIDENTES DOMÉSTICOS Y DE OCIO. RED CENTINELA SANITARIA DE CASTILLA Y LEÓN (2009)

 

Arranz J, Leiva A, Carandell E, Pujol A, Méndez MC, Salvà A, et al. Vigilancia sindrómica de la gripe en atención primaria, un instrumento complementario a las redes centinelas para períodos de elevada incidencia de gripe. Aten Primaria. 2012; 44: 258-264 [T,I]

21924796             R/C

VIGILANCIA SINDRÓMICA DE LA GRIPE EN ATENCIÓN PRIMARIA, UN INSTRUMENTO COMPLEMENTARIO A LAS REDES CENTINELAS PARA PERÍODOS DE ELEVADA INCIDENCIA DE GRIPE

 

Mahtani-Chugani V, López-Hijazo A, Manca D, Sanz-Alvarez E. Comparando las perspectivas de los médicos de atención primaria de Canarias y Alberta. ¿Es más bonito el jardín del vecino que el mío? Aten Primaria. 2012; 44: 265-271 [C,I]

22221963             R/C

COMPARANDO LAS PERSPECTIVAS DE LOS MÉDICOS DE ATENCIÓN PRIMARIA DE CANARIAS Y ALBERTA. ¿ES MÁS BONITO EL JARDÍN DEL VECINO QUE EL MÍO?

 

Pacheco-Huergo V, Viladrich C, Pujol-Ribera E, Cabezas-Peña C, Núñez M, Roura-Olmeda P, et al; en representación del Grupo IPQ-R. Percepción en enfermedades crónicas: validación lingüística del Illness Perception Questionnaire Revised y del Brief Illness Perception Questionnaire para la población española. Aten Primaria. 2012; 44: 280-287 [T,I]

21955598             R/C

PERCEPCIÓN EN ENFERMEDADES CRÓNICAS: VALIDACIÓN LINGÜÍSTICA DEL ILLNESS PERCEPTION QUESTIONNAIRE REVISED Y DEL BRIEF ILLNESS PERCEPTION QUESTIONNAIRE PARA LA POBLACIÓN ESPAÑOLA

 

Vivar CG. Impacto psicosocial del cáncer de mama en la etapa de larga supervivencia: propuesta de un plan de cuidados integral para supervivientes. Aten Primaria. 2012; 44: 288-292 [AO,I]

22019066

IMPACTO PSICOSOCIAL DEL CÁNCER DE MAMA EN LA ETAPA DE LARGA SUPERVIVENCIA: PROPUESTA DE UN PLAN DE CUIDADOS INTEGRAL PARA SUPERVIVIENTES

 

BRITISH JOURNAL OF PSYCHIATRY

 

Williams JM, Kuyken W. Mindfulness-based cognitive therapy: a promising new approach to preventing depressive relapse. Br J Psychiatry. 2012; 200: 359-360 [AO,I]

22550328             R/C

TERAPIA COGNITIVA BASADA EN LA PLENA CONCIENCIA: NUEVO Y PROMETEDOR ABORDAJE PARA PREVENIR LA RECAÍDA DEPRESIVA

 

Morgan AJ, Jorm AF, Mackinnon AJ. Email-based promotion of self-help for subthreshold depression: Mood Memos randomised controlled trial. Br J Psychiatry. 2012; 200: 412-418 [EC,I]

22442102             R/C

PROMOCIÓN DE LA AUTOAYUDA BASADA EN EL CORREO ELECTRÓNICO PARA LA DEPRESIÓN SUBUMBRAL: ENSAYO ALEATORIZADO CONTROLADO MOOD MEMOS

 

BRITISH MEDICAL JOURNAL

 

Bowden-Jones H, Smith N. The medical management of problem gamblers. BMJ. 2012; 344: e1559 [R,I]

22408265

MANEJO MÉDICO DE LOS JUGADORES PROBLEMÁTICOS

 

James C. Doctors' duty to report poor practice. BMJ. 2012; 344: e1695 [AO,II]

22427272

DEBER DE LOS MÉDICOS DE INFORMAR DE LA PRÁCTICA DEFICIENTE

 

Guterman L, McKee M. Severe human rights abuses in healthcare settings. BMJ. 2012; 344: e2013 [AO,I]

22419790

VIOLACIONES GRAVES DE LOS DERECHOS HUMANOS EN LOS DISPOSITIVOS DE ATENCIÓN SANITARIA

 

Varadhan KK, Neal KR, Lobo DN. Safety and efficacy of antibiotics compared with appendicectomy for treatment of uncomplicated acute appendicitis: meta-analysis of randomised controlled trials. BMJ. 2012; 344: e2156 [M,II]

22491789             R/C

SEGURIDAD Y EFICACIA DE LOS ANTIBIÓTICOS EN COMPARACIÓN CON LA APENDICECTOMÍA EN EL TRATAMIENTO DE LA APENDICITIS AGUDA NO COMPLICADA: METAANÁLISIS DE ENSAYOS CONTROLADOS ALEATORIZADOS

 

Nair H, Holmes A, Rudan I, Car J. Influenza vaccination in healthcare professionals. BMJ. 2012; 344: e2217 [R,I]

22457439

VACUNACIÓN CONTRA LA GRIPE EN PROFESIONALES SANITARIOS

 

Bakker OJ. Should conservative treatment of appendicitis be first line? BMJ. 2012; 344: e2546 [AO,I]

22491791

¿DEBERÍA SER DE PRIMERA LÍNEA EL TRATAMIENTO CONSERVADOR DE LA APENDICITIS?

 

Merry SN, Stasiak K, Shepherd M, Frampton C, Fleming T, Lucassen MF. The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ. 2012; 344: e2598 [EC,II]

22517917             R/C

EFECTIVIDAD DE SPARX, INTERVENCIÓN INFORMATIZADA DE AUTOAYUDA PARA ADOLESCENTES QUE BUSCAN AYUDA PARA LA DEPRESIÓN: ENSAYO CONTROLADO DE NO INFERIORIDAD ALEATORIZADO

 

Fisher HL, Moffitt TE, Houts RM, Belsky DW, Arseneault L, Caspi A. Bullying victimisation and risk of self harm in early adolescence: longitudinal cohort study. BMJ. 2012; 344: e2683 [S,I]

22539176             R/C

PERSECUCIÓN Y ACOSO ESCOLAR Y RIESGO DE AUTOLESIONES EN LA ADOLESCENCIA TEMPRANA: ESTUDIO DE COHORTES LONGITUDINAL

 

Poston L, Chappell LC. How should women be advised on weight management in pregnancy? BMJ. 2012; 344: e2774 [R,I]

22596384

¿CÓMO SE DEBERÍA ACONSEJAR A LAS MUJERES SOBRE EL MANEJO DEL PESO  DURANTE EL EMBARAZO?

 

Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ. 2012; 344: e2794 [S,II]

22551713             R/C

VACUNACIÓN CONTRA LA GRIPE PANDÉMICA A/H1N1 DEL 2009 EN EL EMBARAZO Y RIESGO DE MUERTE FETAL: ESTUDIO DE COHORTES EN DINAMARCA

 

Bennett MI, Graham J, Schmidt-Hansen M, Prettyjohns M, Arnold S; On behalf of the Guideline Development Group. Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance. BMJ. 2012; 344: e2806 [M,II]

22623631

PRESCRIPCIÓN DE OPIOIDES FUERTES PARA EL DOLOR EN CUIDADOS PALIATIVOS EN ADULTOS: RESUMEN DE LA GUÍA NICE

 

Farrell M, Wodak A, Gowing L. Maintenance drugs to treat opioid dependence. BMJ. 2012; 344: e2823 [R,I]

22589497

FÁRMACOS DE MANTENIMIENTO PARA TRATAR LA DEPENDENCIA DE OPIOIDES

 

Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012; 344: e2856 [M,II]

22563098             R/C

RIESGO DE ACONTECIMIENTOS CARDIOVASCULARES GRAVES ASOCIADOS CON EL USO DE LA VARENICILINA PARA EL ABANDONO TABÁQUICO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS

 

Bartley M. Economic inactivity and health. BMJ. 2012; 344: e2858 [AO,I]

22573648

INACTIVIDAD ECONÓMICA Y SALUD

 

Rodda J, Carter J. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia. BMJ. 2012; 344: e2986 [R,I]

22550350

INHIBIDORES DE LA COLINESTERASA Y MEMANTINA PARA ELTRATAMIENTO SINTOMÁTICO DE LA DEMENCIA

 

Khan KS, Champaneria R, Latthe PM. How effective are non-drug, non-surgical treatments for primary dysmenorrhoea? BMJ. 2012; 344: e3011 [R,I]

22586231

¿CUÁN EFECTIVOS SON LOS TRATAMIENTOS NO FARMACOLÓGICOS Y NO QUIRÚRGICOS EN LA DISMENORREA PRIMARIA?

 

Leschziner G, Gringras P. Restless legs syndrome. BMJ. 2012; 344: e3056 [R,I]

22623643

SÍNDROME DE PIERNAS INQUIETAS

 

Knight M, Lim B. Immunisation against influenza during pregnancy. BMJ. 2012; 344: e3091 [AO,I]

22551717

INMUNIZACIÓN CONTRA LA GRIPE DURANTE EL EMBARAZO

 

Collins GS, Moons KG. Comparing risk prediction models. BMJ. 2012; 344: e3186 [AO,I]

22628131

COMPARAR LOS MODELOS DE PREDICCIÓN DE RIESGO

 

Siontis GC, Tzoulaki I, Siontis KC, Ioannidis JP. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012; 344: e3318 [M,II]

22628003             R/C

COMPARACIONES DE LOS MODELOS ESTABLECIDOS DEPREDICCIÓN DE RIESGO EN LA ENFERMEDAD CARDIOVASCULAR: REVISIÓN SISTEMÁTICA

 

CANADIAN MEDICAL ASSOCIATION JOURNAL

 

Almadi MA, Barkun JS, Barkun AN. Management of suspected stones in the common bile duct. CMAJ. 2012; 184: 884-892 [R,I]

22508980

MANEJO DE LA SOSPECHA DE CÁLCULOS EN EL CONDUCTO BILIAR

 

Kiddoo DA. Nocturnal enuresis. CMAJ. 2012; 184: 908-911 [AO,I]

22529169

ENURESIS NOCTURNA

 

Mann R, Adamson J, Gilbody SM. Diagnostic accuracy of case-finding questions to identify perinatal depression. CMAJ. 2012; 184: E424-E430 [T,I]

22451686             R/C

EXACTITUD DIAGNÓSTICA DE LAS PREGUNTAS DE DETECCIÓN DE CASOS PARA IDENTIFICAR LA DEPRESIÓN PERINATAL

 

Etminan M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ. 2012; 184: E431-E434 [S,I]

22470169             R/C

EFECTOS ADVERSOS OCULARES INFLAMATORIOS CON EL USO DE BIFOSFONATOS ORALES: ESTUDIO DE COHORTES RETROSPECTIVO

 

CIRCULATION

 

White RH. Identifying risk factors for venous thromboembolism. Circulation. 2012; 125: 2051-2053 [AO,I]

22474263

IDENTIFICAR FACTORES DE RIESGO DE TROMBOEMBOLISMO VENOSO

 

Pikula A, Beiser AS, Decarli C, Himali JJ, Debette S, Au R, et al. Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham offspring study. Circulation. 2012; 125: 2100-2107 [S,II]

22456473             R/C

BIOMARCADORES MÚLTIPLES Y RIESGO DE DAÑO VASCULAR CEREBRAL CLÍNICO Y SUBCLÍNICO: ESTUDIO DE DESCENDENCIA DE FRAMINGHAM

 

Colman E. Food and Drug Administration's obesity drug guidance document: a short history. Circulation. 2012; 125: 2156-2164 [AO,II]

22547756

DOCUMENTO DE LA FDA DE GUÍA DE FÁRMACOS PARA LA OBESIDAD: BREVE HISTORIA

 

Fuster V, Chinitz JS. Net clinical benefit of warfarin: extending the reach of antithrombotic therapy for atrial fibrillation. Circulation. 2012; 125: 2285-2287 [AO,I]

22514253

BENEFICIO CLÍNICO NETO DE LA WARFARINA: EXTENDER EL ALCANCE DE LA TERAPIA ANTITROMBÓTICA DE LA FIBRILACIÓN AURICULAR

 

Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation. 2012; 125: 2298-2307 [S,I]

22514252             R/C

BENEFICIO CLÍNICO DE LA WARFARINA EN PACIENTES CON FIBRILACIÓN AURICULAR: INFORME DEL ESTUDIO DE COHORTES SUECO SOBRE FIBRILACIÓN AURICULAR

 

Topjian AA, Berg RA. Pediatric out-of-hospital cardiac arrest. Circulation. 2012; 125: 2374-2378 [AO,I]

22586292

PARADA CARDIACA PEDIÁTRICA EXTRAHOSPITALARIA

 

Parish S, Offer A, Clarke R, Hopewell JC, Hill MR, Otvos JD, et al; on behalf of the Heart Protection Study Collaborative Group. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection study. Circulation. 2012; 125: 2469-2478 [EC,II]

22539783             R/C

LÍPIDOS Y LIPOPROTEÍNAS Y RIESGO DE DISTINTOS ACONTECIMIENTOS EN EL ESTUDIO DE PROTECCIÓN CARDIACA MRC/BHF

 

Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al; on behalf of the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012; 125: 2520-2544 [M,II]

22514251             R/C

ENFERMEDAD PERIODONTAL Y ENFERMEDAD VASCULAR ATEROSCLERÓTICA: ¿RESPALDA LA EVIDENCIA UNA ASOCIACIÓN INDEPENDIENTE?: DECLARACIÓN CIENTÍFICA DE LA AHA

 

DIABETES CARE

 

Kirkman MS, Schaffner W. Another shot to protect people with diabetes: add hepatitis B vaccination to the checklist. Diabetes Care. 2012; 35: 941-942 [AO,I]

22517936

OTRO INTENTO PARA PROTEGER A LAS PERSONAS CON DIABETES: AÑADIR LA VACUNA DE LA HEPATITIS B A LA LISTA

 

Herman WH, Zimmet P. Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care. 2012; 35: 943-944 [AO,I]

22517937

DIABETES TIPO2: UNA EPIDEMIA QUE REQUIERE ATENCIÓN MUNDIAL Y ACTUACIÓN URGENTE

 

van Dijk JW, Tummers K, Stehouwer CD, Hartgens F, van Loon LJ. Exercise therapy in type 2 diabetes: is daily exercise required to optimize glycemic control? Diabetes Care. 2012; 35: 948-954 [EC,I]

22399700             R/C

TERAPIA DE EJERCICIO EN LA DIABETES TIPO 2: ¿SE NECESITA EJERCICIO DIARIAMENTE PARA OPTIMIZAR EL CONTROL GLUCÉMICO?

 

Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, et al. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012; 35: 976-983 [EC,II]

22374636             R/C

ROMPER CON LA SEDESTACIÓN PROLONGADA REDUCE LA GLUCOSA POSTPRANDIAL Y LAS RESPUESTAS A LA INSULINA

 

Heianza Y, Arase Y, Fujihara K, Hsieh SD, Saito K, Tsuji H, et al. Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7). Diabetes Care. 2012; 35: 1050-1052 [S,II]

22456865             R/C

TRAYECTORIAS LONGITUDINALES DE LOS NIVELES DE GLUCOSA PLASMÁTICA EN AYUNAS Y DE HBA1C DURANTE EL DESARROLLO DE LA DIABETES TIPO 2: ESTUDIO TOPICS 7

 

Tseng PH, Lee YC, Chiu HM, Chen CC, Liao WC, Tu CH, et al. Association of diabetes and HbA1c levels with gastrointestinal manifestations. Diabetes Care. 2012; 35: 1053-1060 [T,I]

22410812             R/C

ASOCIACIÓN DE DIABETES Y NIVELES DE HBA1C CON MANIFESTACIONES GASTROINTESTINALES

 

Williams ED, Rawal L, Oldenburg BF, Renwick C, Shaw JE, Tapp RJ. Risk of cardiovascular and all-cause mortality: impact of impaired health-related functioning and diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Care. 2012; 35: 1067-1073 [S,II]

22446177             R/C

RIESGO DE MORTALIDAD CARDIOVASCULAR Y POR CUALQUIER OTRA CAUSA: IMPACTO DE LA FUNCIONALIDAD RELACIONADA CON ALTERACIÓN DE LA SALUD Y DE LA DIABETES: ESTUDIO AUSDIAB

 

Thomas GN, O Hartaigh B, Bosch JA, Pilz S, Loerbroks A, Kleber ME, et al. Vitamin D levels predict all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Diabetes Care. 2012; 35: 1158-1164 [S,II]

22399697             R/C

LOS NIVELES DE VITAMINA D PREDICEN LA MORTALIDAD POR ENFERMEDAD CARDIOVASCULAR Y POR CUALQUIER OTRA CAUSA EN SUJETOS CON SÍNDROME METABÓLICO: ESTUDIO LURIC

 

Best JD, Drury PL, Davis TM, Taskinen MR, Kesäniemi YA, Scott R, et al; on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators. Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. Diabetes Care. 2012; 35: 1165-1170 [S,II]

22432105             R/C

CONTROL GLUCÉMICO A LO LARGO DE 5 AÑOS EN 4.900 PERSONAS CON DIABETES TIPO 2: TRATAMIENTO DE LA DIABETES EN EL ENTORNO REAL EN UN ENSAYO CLÍNICO DE COHORTES

 

Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012; 35: 1171-1180 [M,I]

22517938             R/C

ASOCIACIÓN BIDIRECCIONAL ENTRE DEPRESIÓN Y SÍNDROME METABÓLICO: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE ESTUDIOS EPIDEMIOLÓGICOS

 

DRUGS

 

Roth SH. Coming to terms with nonsteroidal anti-inflammatory drug gastropathy. Drugs. 2012; 72: 873-879 [R,I]

22564130             R/C

PONERSE DE ACUERDO EN CUANTO A LA GASTROPATÍA POR AINE

 

Stewart SE, Hezel D, Stachon AC. Assessment and medication management of paediatric obsessive-compulsive disorder. Drugs. 2012; 72: 881-893 [R,II]

22564131             R/C

VALORACIÓN Y MANEJO DE LA MEDICACIÓN EN EL TRASTORNO OBSESIVO-COMPULSIVO PEDIÁTRICO

 

EUROPEAN HEART JOURNAL

 

Swedberg K, Komajda M. The beat goes on: on the importance of heart rate in chronic heart failure. Eur Heart J. 2012; 33: 1044-1045 [AO,I]

22408032

EL LATIDO CONTINÚA: SOBRE LA IMPORTANCIA DE LA FRECUENCIA CARDIACA EN LA INSUFICIENCIA CARDIACA CRÓNICA

 

Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012; 33: 1058-1066 [R,I]

22507981             R/C

EL SISTEMA NERVIOSO SIMPÁTICO HUMANO: SU RELEVANCIA EN LA HIPERTENSIÓN Y LA INSUFICIENCIA CARDIACA

 

Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. Eur Heart J. 2012; 33: 1137-1141 [AO,I]

22408030             R/C

¿DEBERÍAMOS CAMBIAR (SHIFT, por el estudio SHIFT) NUESTRA FORMA DE PENSAR RESPECTO A LA DIGOXINA? OBSERVACIONES SOBRE LA IVABRADINA Y LA REDUCCIÓN DE LA FRECUENCIA CARDIACA EN LA INSUFICIENCIA CARDIACA

 

Gurbel PA, Ohman EM, Jeong YH, Tantry US. Toward a therapeutic window for antiplatelet therapy in the elderly. Eur Heart J. 2012; 33: 1187-1189 [R,I]

22270540

HACIA UNA VENTANA TERAPÉUTICA EN LA TERAPIA ANTIPLAQUETARIA EN LOS ANCIANOS

 

Bhatia LS, Curzen NP, Calder PC, Byrne CD. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J. 2012; 33: 1190-1200 [R,I]

22408036             R/C

ENFERMEDAD DE HÍGADO GRASO NO ALCOHÓLICO: ¿UN NUEVO E IMPORTANTE FACTOR DE RIESGO CARDIOVASCULAR?

 

FAMILY MEDICINE

 

Green MJ, Masters R, James B, Simmons B, Lehman E. Do gifts from the pharmaceutical industry affect trust in physicians? Fam Med. 2012; 44: 325-331 [T,I]

                R/C

¿AFECTAN A LA CONFIANZA EN LOS MÉDICOS LOS REGALOS DE LA INDUSTRIA FARMACÉUTICA?

 

Reilly JM, Gravdal JA. An ecological model for family violence prevention across the life cycle. Fam Med. 2012; 44: 332-335 [R,I]

MODELO ECOLÓGICO PARA LA PREVENCIÓN DE LA VIOLENCIA FAMILIAR DURANTE EL CICLO VITAL

 

Kruse RL, Koopman RJ, Wakefield BJ, Wakefield DS, Keplinger LE, Canfield SM, et al. Internet use by primary care patients: where is the digital divide? Fam Med. 2012; 44: 342-347 [T,I]

                R/C

USO DE INTERNET POR LOS PACIENTES DE ATENCIÓN PRIMARIA: ¿DÓNDE ESTÁ LA DIVISORIA DIGITAL?

 

George P, Reis S, Nothnagle M. Using a learning coach to teach residents evidence-based medicine. Fam Med. 2012; 44: 351-355 [QE,I]

                R/C

USAR UN MONITOR DE APRENDIZAJE PARA ENSEÑAR A LOS RESIDENTES LA MEDICINA BASADA EN LA EVIDENCIA

 

GUT

 

Janssen HL, Sonneveld MJ, Brunetto MR. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? Gut. 2012; 61: 641-645 [AO,I]

22180061

CUANTIFICACIÓN DEL ANTÍGENO DE SUPERFICIE DE LA HEPATITIS B: ¿ES ÚTIL EN EL MANEJO DE LA HEPATITIS B CRÓNICA?

 

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al; The European Helicobacter Study Group (EHSG). Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012; 61: 646-664 [M,II]

22491499             R/C

MANEJO DE LA INFECCIÓN POR HELICOBACTER PYLORI--INFORME DE CONSENSO MAASTRICHT IV/FLORENCIA

 

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE

 

Dumont IP, Olson AL. Primary care, depression, and anxiety: exploring somatic and emotional predictors of mental health status in adolescents. J Am Board Fam Med. 2012; 25: 291-299 [T,I]

22570392             R/C

ATENCIÓN PRIMARIA, DEPRESIÓN Y ANSIEDAD: EXPLORAR LOS PREDICTORES SOMÁTICOS Y EMOCIONALES DEL ESTADO DE SALUD MENTAL EN ADOLESCENTES

 

Sadowsky CH, Galvin JE. Guidelines for the management of cognitive and behavioral problems in dementia. J Am Board Fam Med. 2012; 25: 350-366 [M,II]

22570399             R/C

PAUTAS PARA EL MANEJO DE LOS PROBLEMAS COGNITIVOS Y CONDUCTUALES EN LA DEMENCIA

 

Galvin JE, Sadowsky CH. Practical guidelines for the recognition and diagnosis of dementia. J Am Board Fam Med. 2012; 25: 367-382 [M,II]

22570400             R/C

GUÍAS PRÁCTICAS PARA EL RECONOCIMIENTO Y DIAGNÓSTICO DE LA DEMENCIA

 

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

 

Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012; 307: 1801-1802 [AO,I]

22492759

ESCOGER CON DISCERNIMIENTO: AYUDAR A LOS MÉDICOS Y A LOS PACIENTES A TOMAR DECISIONES INTELIGENTES SOBRE SU ATENCIÓN

 

Christian P, Black RE. Food, micronutrients, and birth outcomes. JAMA. 2012; 307: 2094-2096 [AO,I]

22665110

COMIDA, MICRONUTRIENTES Y RESULTADOS EN EL NACIMIENTO

 

MEDICINA CLINICA

 

Pérez A, Franch J, Cases A, González JR, Conthe P, Gimeno E, et al. Relación del grado de control glucémico con las características de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES. Med Clin (Barc). 2012; 138: 505-511 [T,II]

22118974             R/C

RELACIÓN DEL GRADO DE CONTROL GLUCÉMICO CON LAS CARACTERÍSTICAS DE LA DIABETES Y EL TRATAMIENTO DE LA HIPERGLUCEMIA EN LA DIABETES TIPO 2. ESTUDIO DIABES

 

Llisterri JL, Barrios V, de la Sierra A, Escobar C, González-Segura D. Prevalencia de enfermedad renal crónica en mujeres hipertensas de edad avanzada atendidas en atención primaria. Estudio MERICAP. Med Clin (Barc). 2012; 138: 512-518 [T,I]

21944650             R/C

PREVALENCIA DE ENFERMEDAD RENAL CRÓNICA EN MUJERES HIPERTENSAS DE EDAD AVANZADA ATENDIDAS EN ATENCIÓN PRIMARIA

 

Soriguer F, Ruiz de Adana MS. Calidad de la asistencia a los pacientes con diabetes mellitus tipo 2 en España. Med Clin (Barc). 2012; 138: 522-524 [AO,I]

22118976

CALIDAD DE LA ASISTENCIA A LOS PACIENTES CON DIABETES MELLITUS TIPO 2 EN ESPAÑA

 

Calatrava M, López-Del Burgo C, de Irala J. Factores de riesgo relacionados con la salud sexual en los jóvenes europeos. Med Clin (Barc). 2012; 138: 534-540 [R,I]

22015005             R/C

FACTORES DE RIESGO RELACIONADOS CON LA SALUD SEXUAL EN LOS JÓVENES EUROPEOS

 

García-Donaire JA, Dalfó A, Sanclemente C, Urdiales D, Martínez F, Ortega N, et al. Medida de la presión arterial en consulta y automatizada (BPTru®) para evaluar el efecto de bata blanca. Med Clin (Barc). 2012; 138: 597-601 [EC,I]

22440145             R/C

MEDIDA DE LA PRESIÓN ARTERIAL EN CONSULTA Y AUTOMATIZADA (BPTRU®) PARA EVALUAR EL EFECTO DE BATA BLANCA

 

Quirós R, García J, Martín MD, Trujillo J, Villena MÁ, Perea E. Factores pronósticos y supervivencia a largo plazo tras el diagnóstico inicial de insuficiencia cardiaca. Med Clin (Barc). 2012; 138: 602-608 [S,I]

21663923             R/C

FACTORES PRONÓSTICOS Y SUPERVIVENCIA A LARGO PLAZO TRAS EL DIAGNÓSTICO INICIAL DE INSUFICIENCIA CARDIACA

 

Clua-Espuny JL, Piñol-Moreso JL, Gil-Guillén FV, Orozco-Beltran D, Panisello-Tafalla A, Lucas-Noll J. La atención sanitaria del ictus en el área Terres de l’Ebre desde la implantación del Código Ictus: Estudio Ebrictus. Med Clin (Barc). 2012; 138: 609-611 [S,II]

22153783             R/C

LA ATENCIÓN SANITARIA DEL ICTUS EN EL ÁREA TERRES DE L’EBRE DESDE LA IMPLANTACIÓN DEL CÓDIGO ICTUS: ESTUDIO EBRICTUS

 

Camafort M, Coca A. Medir apropiadamente la presión arterial. ¿Cuestión de precisión o de simplicidad? Med Clin (Barc). 2012; 138: 612-613 [AO,I]

22440142

MEDIR APROPIADAMENTE LA PRESIÓN ARTERIAL. ¿CUESTIÓN DE PRECISIÓN O DE SIMPLICIDAD?

 

Ruano-Ravina A. Sociedades científicas y su relación económica con la industria. Situación en España. Med Clin (Barc). 2012; 138: 614-616 [AO,I]

22440141

SOCIEDADES CIENTÍFICAS Y SU RELACIÓN ECONÓMICA CON LA INDUSTRIA. SITUACIÓN EN ESPAÑA

 

Bolíbar B, Fina F, Morros R, Garcia-Gil MdM, Hermosilla E, Ramos R, et al; en representación del Grupo SIDIAP. Base de datos SIDIAP: la historia clínica informatizada de Atención Primaria como fuente de información para la investigación epidemiológica. Med Clin (Barc). 2012; 138: 617-621 [R,I]

22444996

BASE DE DATOS SIDIAP: LA HISTORIA CLÍNICA INFORMATIZADA DE ATENCIÓN PRIMARIA COMO FUENTE DE INFORMACIÓN PARA LA INVESTIGACIÓN EPIDEMIOLÓGICA

 

Revuelta G. Salud en España durante el período 2000-2009: aproximación a través del análisis de la prensa. Med Clin (Barc). 2012; 138: 622-626 [R,I]

21621230

SALUD EN ESPAÑA DURANTE EL PERÍODO 2000-2009: APROXIMACIÓN A TRAVÉS DEL ANÁLISIS DE LA PRENSA

 

Fuster D, Tor J, Rey-Joly C, Muga R. Interacciones patogénicas entre alcohol y hepatitis C. Med Clin (Barc). 2012; 138: 627-632 [R,I]

21696783

INTERACCIONES PATOGÉNICAS ENTRE ALCOHOL Y HEPATITIS C

 

Grau-Amorós J, Formiga F, Aramburu O, Recio-Iglesias J, Trullàs JC, Urrutia A. Anemia en la insuficiencia cardiaca: su utilidad como marcador de pronóstico o de comorbilidad: estudio GESAIC-2. Med Clin (Barc). 2012; 138: 656-659 [S,II]

22397982             R/C

ANEMIA EN LA INSUFICIENCIA CARDIACA: SU UTILIDAD COMO MARCADOR DE PRONÓSTICO O DE COMORBILIDAD: ESTUDIO GESAIC-2

 

Caminero JA. Tuberculosis multirresistente. Med Clin (Barc). 2012; 138: 660-662 [AO,I]

22401731

TUBERCULOSIS MULTIRRESISTENTE

 

Sopena N. Higiene de manos para una atención más segura. Med Clin (Barc). 2012; 138: 663-665 [AO,I]

22459576

HIGIENE DE MANOS PARA UNA ATENCIÓN MÁS SEGURA

 

Pérez A, Gómez R, Alvarez F, García J, Mediavilla JJ, Menéndez E. Documento de consenso sobre el tratamiento al alta hospitalaria del paciente con hiperglucemia. Med Clin (Barc). 2012; 138: 666.e1-e10 [M,II]

22503128             R/C

DOCUMENTO DE CONSENSO SOBRE EL TRATAMIENTO AL ALTA HOSPITALARIA DEL PACIENTE CON HIPERGLUCEMIA

 

Roca-Cusachs A; en nombre del Grupo de trabajo sobre hipertensión arterial y política de salud en Cataluña. Hipertensión arterial y política de salud en Cataluña: de la teoría a la práctica. Med Clin (Barc). 2012; 138: 678-683 [R,I]

22197367

HIPERTENSIÓN ARTERIAL Y POLÍTICA DE SALUD EN CATALUÑA: DE LA TEORÍA A LA PRÁCTICA

 

REUMATOLOGIA CLINICA

 

Pueyo MJ, Larrosa M, Surís X, Garcia-Ruiz AJ. Análisis de coste-utilidad e impacto presupuestario de la prevención primaria con alendronato de la fractura osteoporótica de cadera en Cataluña. Reumatol Clin.  2012; 8: 128-134 [CE,II]

22421456             R/C

ANÁLISIS DE COSTE-UTILIDAD E IMPACTO PRESUPUESTARIO DE LA PREVENCIÓN PRIMARIA CON ALENDRONATO DE LA FRACTURA OSTEOPORÓTICA DE CADERA EN CATALUÑA

 

Romero CM, Manrique S, Rodríguez M. Marcadores bioquímicos en osteoporosis. Utilidad en la práctica clínica.  Reumatol Clin.  2012; 8: 149-152 [R,I]

22089065             R/C

MARCADORES BIOQUÍMICOS EN OSTEOPOROSIS. UTILIDAD EN LA PRÁCTICA CLÍNICA

 

REVISTA ESPAÑOLA DE CARDIOLOGIA

 

Vrints CJ. Mejora de la calidad de la asistencia en el infarto agudo de miocardio: es necesario prestar mayor atención al tratamiento médico óptimo a largo plazo y a la prevención secundaria. Rev Esp Cardiol. 2012; 65: 401-402 [AO,I]

22425437

MEJORA DE LA CALIDAD DE LA ASISTENCIA EN EL INFARTO AGUDO DE MIOCARDIO: ES NECESARIO PRESTAR MAYOR ATENCIÓN AL TRATAMIENTO MÉDICO ÓPTIMO A LARGO PLAZO Y A LA PREVENCIÓN SECUNDARIA

 

Srikanthan P, Horwich TB. La paradoja de la obesidad: es hora de adoptar una perspectiva nueva sobre un paradigma antiguo. Rev Esp Cardiol. 2012; 65: 403-404 [AO,I]

22406399

LA PARADOJA DE LA OBESIDAD: ES HORA DE ADOPTAR UNA PERSPECTIVA NUEVA SOBRE UN PARADIGMA ANTIGUO

 

THE LANCET

 

Blum RW, Bastos FI, Kabiru CW, Le LC. Adolescent health in the 21st century. Lancet. 2012; 379: 1567-1568 [AO,I]

22538177

SALUD DEL ADOLESCENTE EN ELSIGLO 21

 

Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of  incident cancers during randomised controlled trials. Lancet. 2012; 379: 1591-1601 [M,II]

22440947             R/C

EFECTO DE LA ASPIRINA DIARIA SOBRE EL RIESGO DE METÁSTASIS DE CÁNCER: ESTUDIO DE INCIDENCIA DE CÁNCERES DURANTE ENSAYOS CONTROLADOS ALEATORIZADOS

 

Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012; 379: 1602-1612 [M,II]

22440946             R/C

EFECTOS A CORTO PLAZO DE LA ASPIRINA DIARIA SOBRE LA INCIDENCIA DE CÁNCER, MORTALIDAD Y MUERTE NO VASCULAR: ANÁLISIS DEL CURSO A LO LARGO DEL TIEMPO DE LOS RIESGOS Y LOS BENEFICIOS EN 51 ENSAYOS CONTROLADOS ALEATORIZADOS

 

Hughes K, Bellis MA, Jones L, Wood S, Bates G, Eckley L, et al. Prevalence and risk of violence against adults with disabilities: a systematic review and meta-analysis of observational studies. Lancet. 2012; 379: 1621-1629 [M,II]

22377290             R/C

PREVALENCIA Y RIESGO DE VIOLENCIA CONTRA ADULTOS CON DISCAPACIDADES: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE ESTUDIOS OBSERVACIONALES

 

Sawyer SM, Afifi RA, Bearinger LH, Blakemore SJ, Dick B, Ezeh AC, et al. Adolescence: a foundation for future health. Lancet. 2012; 379: 1630-1640 [R,I]

22538178             R/C

ADOLESCENCIA: CIMIENTOS DE LA SALUD FUTURA

 

Viner RM, Ozer EM, Denny S, Marmot M, Resnick M, Fatusi A, et al. Adolescence and the social determinants of health. Lancet. 2012; 379: 1641-1652 [R,I]

22538179             R/C

ADOLESCENCIA Y DETERMINANTES SOCIALES DE LA SALUD

 

Catalano RF, Fagan AA, Gavin LE, Greenberg MT, Irwin CE Jr, Ross DA, et al. Worldwide application of prevention science in adolescent health. Lancet. 2012; 379: 1653-1664 [R,I]

22538180             R/C

APLICACIÓN MUNDIAL DE LA CIENCIA DE LA PREVENCIÓN EN LA SALUD DEL ADOLESCENTE

 

Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012; 379: 1728-1738 [AO,I]

DEGENERACIÓN MACULAR RELACIONADA CON LA EDAD

 

Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012; 379: 1739-1748 [R,I]

22559900             R/C

MIOPÍA

 

Caritis SN, Simhan H. Cervical pessary use and preterm birth: how little we know. Lancet. 2012; 379: 1769-1770 [AO,I]

22475492

USO DE PESARIO CERVICAL Y PARTO PREMATURO: QUÉ POCO CONOCEMOS

 

Templeton A. Misoprostol for all women seeking abortion? Lancet. 2012; 379: 1772-1773 [AO,I]

22405253

¿MISOPROSTOL PARA TODAS LAS MUJERES QUE BUSCAN ABORTAR?

 

Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A, et al; Pesario Cervical para Evitar Prematuridad (PECEP) Trial Group.  Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet. 2012; 379: 1800-1806

[EC,I]

22475493             R/C

PESARIO CERVICAL EN MUJERES EMBARAZADAS CON CÉRVIX CORTO: ENSAYO CONTROLADO ALEATORIZADO NO ENMASCARADO

 

Chronic disease management in ageing populations. Lancet. 2012; 379: 1851 [AO,I]

22608320

MANEJO DE LA ENFERMEDAD CRÓNICA EN POBLACIONES ENVEJECIDAS

 

Tobacco industry versus tobacco control. Lancet. 2012; 379: 1924 [AO,I]

22633021

INDUSTRIA DEL TABACO FRENTE A CONTROL DEL TABACO

 

Langguth B. Tinnitus: the end of therapeutic nihilism. Lancet. 2012; 379: 1926-1928 [AO,I]

22633023

ACÚFENOS: FIN DEL NIHILISMO TERAPÉUTICO

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

Lamas D, Rosenbaum L. Freedom from the tyranny of choice--teaching the end-of-life conversation. N Engl J Med. 2012; 366: 1655-1657 [AO,I]

22551124

LIBERARSE DE LA TIRANÍA DE ELEGIR-- ENSEÑAR LA CONVERSACIÓN DEL FINAL DE LA VIDA

 

Alexander EK, Larsen PR. Radioiodine for thyroid cancer--is less more? N Engl J Med. 2012; 366: 1732-1733 [AO,I]

22551133

RADIOYODO EN EL CÁNCER DE TIROIDES-- ¿MENOS ES MÁS?

 

Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycin and the risk of cardiovascular death. N Engl J Med. 2012; 366: 1881-1890 [S,I]

22591294             R/C

AZITROMICINA Y RIESGO DE MUERTE CARDIOVASCULAR

 

Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012; 366: 1891-1904 [S,I]

22591295             R/C

ASOCIACIÓN ENTRE BEBER CAFÉ Y MORTALIDAD TOTAL Y POR CAUSAS ESPECÍFICAS

 

Davis SM, Donnan GA. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med. 2012; 366: 1914-1922 [R,I]

22591297

PRÁCTICA CLÍNICA. PREVENCIÓN SECUNDARIA TRAS ICTUS ISQUÉMICO O ATAQUE ISQUÉMICO TRANSITORIO

 

Eikelboom JW, Connolly SJ. Warfarin in heart failure. N Engl J Med. 2012; 366: 1936-1938 [AO,I]

22551103

WARFARINA EN LA INSUFICIENCIA CARDIACA

 

Ghorob A, Bodenheimer T. Sharing the care to improve access to primary care. N Engl J Med. 2012; 366: 1955-1957 [AO,I]

22621625

COMPARTIR LA ATENCIÓN PARA MEJORAR EL ACCESO A LA ATENCIÓN PRIMARIA

 

Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, et al; WARFASA Investigators. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med. 2012; 366: 1959-1967 [EC,II]

22621626             R/C

ASPIRINA PARA PREVENIR LA RECURRENCIA DEL TROMBOEMBOLISMO VENOSO

 

Becker RC. Aspirin and the prevention of venous thromboembolism. N Engl J Med. 2012; 366: 2028-2030 [AO,I]

22621631

ASPIRINA Y PREVENCIÓN  DEL TROMBOEMBOLISMO VENOSO

 

Whitaker M, Guo J, Kehoe T, Benson G. Bisphosphonates for osteoporosis--where do we go from here? N Engl J Med. 2012; 366: 2048-2051 [AO,I]

22571168

BIFOSFONATOS PARA LA OSTEOPOROSIS ¿A DÓNDE VAMOS DESDE AQUÍ?

 

Black DM, Bauer DC, Schwartz AV, Cummings SR, Rosen CJ. Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? N Engl J Med. 2012; 366: 2051-2053 [AO,I]

22571169

CONTINUACIÓN DEL TRATAMIENTO CON BIFOSFONATOS PARA LA OSTEOPOROSIS ¿PARA QUIÉN Y DURANTE CUÁNTO TIEMPO?

 

THORAX

 

Peake MD. Should we be pursuing the earlier diagnosis of lung cancer in symptomatic patients? Thorax. 2012; 67: 379-380 [AO,I]

22426900

¿DEBERÍAMOS PERSEGUIR EL DIAGNÓSTICO MÁS PRECOZ DEL CÁNCER DE PULMÓN EN PACIENTES SINBTOMÁTICOS?

 

Athey VL, Suckling RJ, Tod AM, Walters SJ, Rogers TK. Early diagnosis of lung cancer: evaluation of a community-based social marketing intervention. Thorax. 2012; 67: 412-417 [QE,I]

22052579             R/C

DIAGNÓSTICO PRECOZ DE CÁNCER DE PULMÓN: EVALUACIÓN DE UNA INTERVENCIÓN DE MARKETING SOCIAL COMUNITARIO

 

ANNALS OF INTERNAL MEDICINE

 

S22586006

A CCMP in patients with severe COPD had not decreased COPD-related hospitalizations when the trial was stopped prematurely. The CCMP was associated with unanticipated excess mortality, results that differ markedly from similar previous trials. A data monitoring committee should be considered in the design of clinical trials involving behavioral interventions.

S22547473

Extremely dense breasts and first-degree relatives with breast cancer were each associated with at least a 2-fold increase in risk for breast cancer in women aged 40 to 49 years. Identification of these risk factors may be useful for personalized mammography screening.

S22586009

Most studies that are cited for the risk for CRC when relatives have adenomas do not address the issue. The 2 studies that do address the issue suggest an increased risk but have important methodological limitations. Properly designed studies are needed to measure the risk and identify the factors that modify it.

S22412038

Compared with LMWH, lower doses of oral factor Xa inhibitors can achieve a small absolute risk reduction in symptomatic deep venous thrombosis without increasing bleeding.

S22547472

Threshold concentrations of 25-(OH)D associated with increased risk for relevant clinical disease events center near 50 nmol/L (20 ng/mL). Season-specific targets for 25-(OH)D concentration may be more appropriate than static targets when evaluating health risk

S22547470

Women aged 40 to 49 years with a 2-fold increased risk have similar harm-benefit ratios for biennial screening mammography as average-risk women aged 50 to 74 years. Threshold RRs required for favorable harm-benefit ratios vary by screening method, interval, and outcome measure.

 

 

ACADEMIC MEDICINE

 

S22450184

The Accreditation Council for Continuing Medical Education mandates that continuing medical education (CME) be developed around professional practice gaps. Accordingly, CME course directors must identify the intended learners, assess learners' needs, identify gaps in knowledge, and evaluate their CME activities. Writing gap statements is challenging for CME course directors because there is not a universally accepted format for writing these statements. The authors describe a practical approach to defining gaps for CME accreditation, which involves four steps indicated by the mnemonic LASO (learner, assessment, standard, outcomes): (1) define the learner population's characteristics, (2) create a learning needs assessment, (3) determine if the standard is met, and (4) state educational outcome for the CME activity. Based on this model, the difference between the practice standard and the current practice represents the gap in practice. The LASO approach has assisted in making CME content learner centered, relevant, and measurable at the authors' institution. The authors anticipate that LASO will be able to provide all CME course directors with a practical approach to defining educational gaps for CME accreditation.

S22450183
The 2002 reformatting of the standards enhanced the clarity of each standard and connected previously existing annotations to their standards. As a result of the reformatting, all documents and communications to schools were directly tied to specific standards. This has allowed the LCME to more easily identify areas of chronic noncompliance and to improve survey team training. The shift in patterns of standards out of compliance in the more recent time period is consistent with the effect of the reformatting. There may be other contributing factors for the increase in severe action decisions, but it is clear that the reformatting of standards has improved the LCME's ability to monitor medical education programs.

 

ARTHRITIS AND RHEUMATISM

 

S22135156
The present longitudinal study revealed a high incidence of radiographic knee OA in Japan.

S22139828 
Our findings indicate that patients with erosive OA have more functional impairment and significantly more pain compared to patients with controlled inflammatory arthritis affecting the hands. This highlights the significant clinical burden of erosive OA and warrants the search for new treatment strategies.

S22287295 
Our findings, in one of the largest studies to systematically assess lumbar disc degeneration on MRI, indicated a significant association between the presence, extent, and global severity of disc degeneration with weight in overweight and obese adults.

S22139851 
Our findings provide the first US national prevalence estimates for HLA-B27. A decline in the prevalence of HLA-B27 with age is suggested by these data but must be confirmed by additional studies.

 

ARCHIVES OF INTERNAL MEDICINE

 

S22493407
Our meta-analysis showed insufficient evidence of a secondary preventive effect of omega-3 fatty acid supplements against overall cardiovascular events among patients with a history of cardiovascular disease.

 

ARCHIVOS DE BRONCONEUMOLOGIA

 

S22364671
En este artículo revisamos primero por pruebas (espirometría, prueba de reversibilidad, flujo espiratorio pico, volúmenes pulmonares, presiones respiratorias máximas, transferencia de monóxido de carbono, gasometría arterial, prueba de marcha de 6min y desaturación con ejercicio y ergoespirometría), y luego por patologías más frecuentes (disnea no aclarada, tos crónica, asma, EPOC, enfermedades neuromusculares, enfermedades intersticiales, enfermedades vasculares pulmonares, valoración preoperatoria y valoración de la discapacidad), la utilidad de las pruebas funcionales respiratorias más habituales desde la perspectiva de la toma de decisiones, de la interpretación clínica o de aspectos que el clínico debe tener en cuenta a la hora de utilizarlas. En consecuencia, no se incide en aspectos de calidad, de la técnica ni de los equipos, salvo referencia a los costos, porque pensamos que es un elemento importante en la toma de decisiones. El documento está ampliamente fundamentado con referencias a la literatura.

 

ATENCION PRIMARIA

 

S22221963
Los resultados de este estudio permiten hacer una crítica constructiva sobre el papel del médico en atención primaria, valorar las ventajas y replantearnos los inconvenientes relacionados con nuestra forma de trabajar con el fin de aprender de otros sistemas organizativos.

S21955598
Tras la validación lingüística del IPQ-Re y del BIPQ, se obtuvieron versiones conceptual y lingüísticamente equivalentes a los cuestionarios originales.

S21924796
Creemos que un sistema de vigilancia sindrómica, basado en la historia electrónica de atención primaria, permite acceder en tiempo real a la información, muy útil especialmente en los períodos de elevada incidencia de gripe como los períodos epidémicos o la pasada pandemia.

S21733598
El accidente se produjo, fundamentalmente, en el hogar, en día laborable y como consecuencia de caídas. Los grupos de edad más afectados fueron los menores de 15 años y = 65 años.

 

BRITISH JOURNAL OF PSYCHIATRY

 

S22550328
Mindfulness-based cognitive therapy (MBCT) was developed as a psychological approach for people at risk for depressive relapse who wish to learn how to stay well in the long-term. In this article we set out the rationale for MBCT, outline the treatment approach, overview the efficacy research to date and look to future challenges

S22442102
Emails promoting self-help strategies were beneficial. Internet delivery of self-help messages affords a low-cost, easily disseminated and highly automated approach for indicated prevention of depression.

 

BRITISH MEDICAL JOURNAL

 

S22539176
Prevention of non-suicidal self injury in young adolescents should focus on helping bullied children to cope more appropriately with their distress. Programmes should target children who have additional mental health problems, have a family history of attempted/completed suicide, or have been maltreated by an adult.

S22628003
Several risk prediction models for cardiovascular disease are available and their head to head comparisons would benefit from standardised reporting and formal, consistent statistical comparisons. Outcome selection and optimism biases apparently affect this literature.

S22563098
This meta-analysis-which included all trials published to date, focused on events occurring during drug exposure, and analysed findings using four summary estimates-found no significant increase in cardiovascular serious adverse events associated with varenicline use. For rare outcomes, summary estimates based on absolute effects are recommended and estimates based on the Peto odds ratio should be avoided.

S22491789
Antibiotics are both effective and safe as primary treatment for patients with uncomplicated acute appendicitis. Initial antibiotic treatment merits consideration as a primary treatment option for early uncomplicated appendicitis.

S22551713
This large cohort study found no evidence of an increased risk of fetal death associated with exposure to an adjuvanted pandemic A/H1N1 2009 influenza vaccine during pregnancy.

S22517917
SPARX is a potential alternative to usual care for adolescents presenting with depressive symptoms in primary care settings and could be used to address some of the unmet demand for treatment.

 

CANADIANMEDICAL ASSOCIATIONB JOURNAL

 

S22470169

People using oral bisphosphonates for the first time may be at a higher risk of scleritis and uveitis compared to people with no bisphosphonate use. Patients taking bisphosphonates must be familiar with the signs and symptoms of these conditions, so that they can immediately seek assessment by an ophthalmologist.

S22451686

Negative responses to both of the case-finding questions showed acceptable accuracy for ruling out perinatal depression. For positive responses, the use of a third question about the need for help improved specificity and the ability to rule in depression.

 

CIRCULATION

 

S22456473
In a middle-aged community sample, we identified multiple biomarkers that were associated with clinical and subclinical vascular brain injury and could improve risk stratification.

S22514252
In almost all patients with atrial fibrillation, the risk of ischemic stroke without anticoagulant treatment is higher than the risk of intracranial bleeding with anticoagulant treatment. Analysis of the net benefit indicates that more patients may benefit from anticoagulant treatment.

S22539783
In a population at 2% average coronary event risk per year, cholesterol, apolipoprotein, and particle measures of LDL were strongly correlated and had similar predictive values for incident major occlusive vascular events. It is unclear whether the associations between HDL particle numbers and other cardiac events represent a causal or reverse-causal effect.

S22514251
A link between oral health and cardiovascular disease has been proposed for more than a century. Recently, concern about possible links between periodontal disease (PD) and atherosclerotic vascular disease (ASVD) has intensified and is driving an active field of investigation into possible association and causality. The 2 disorders share several common risk factors, including cigarette smoking, age, and diabetes mellitus. Patients and providers are increasingly presented with claims that PD treatment strategies offer ASVD protection; these claims are often endorsed by professional and industrial stakeholders. The focus of this review is to assess whether available data support an independent association between ASVD and PD and whether PD treatment might modify ASVD risks or outcomes. It also presents mechanistic details of both PD and ASVD relevant to this topic. The correlation of PD with ASVD outcomes and surrogate markers is discussed, as well as the correlation of response to PD therapy with ASVD event rates. Methodological issues that complicate studies of this association are outlined, with an emphasis on the terms and metrics that would be applicable in future studies. Observational studies to date support an association between PD and ASVD independent of known confounders. They do not, however, support a causative relationship. Although periodontal interventions result in a reduction in systemic inflammation and endothelial dysfunction in short-term studies, there is no evidence that they prevent ASVD or modify its outcomes.

 

DIABETES CARE

 

S22410812
DM and higher levels of HbA(1c) were associated with lower prevalence of GI symptoms but higher prevalence of endoscopic abnormalities.

S22517938
Our results indicate a bidirectional association between depression and MetS. These results support early detection and management of depression among patients with MetS and vice versa.

S22374636
Interrupting sitting time with short bouts of light- or moderate-intensity walking lowers postprandial glucose and insulin levels in overweight/obese adults. This may improve glucose metabolism and potentially be an important public health and clinical intervention strategy for reducing cardiovascular risk.

S22432105
With intensification of traditional therapies, glycemic control deteriorated very little over 5 years in a large cohort of type 2 diabetes. However, the requirement for insulin therapy doubled, at the expense of significant weight gain and risk of hypoglycemia.

S22456865
HbA(1c) trajectory increased sharply after gradual long-term increases in diabetic individuals.

S22446177
This study demonstrates that the combination of diabetes and impaired HRF is associated with substantially higher CVD mortality. This suggests that, among those with diabetes, impaired HRF is likely to be important in the identification of individuals at increased risk of CVD mortality.

S22399700
A short 30-min session of moderate-intensity endurance-type exercise substantially reduces the prevalence of hyperglycemia throughout the subsequent day in type 2 diabetic patients. When total work is being matched, daily exercise does not further improve daily glycemia compared with exercise performed every other day.

S22399697
Optimal 25(OH)D levels substantially lowered all-cause and cardiovascular disease mortality in subjects with the metabolic syndrome. These observations call for interventional studies that test whether vitamin D supplementation provides a useful adjunct in reducing mortality in these subjects.

 

DRUGS

 

S22564130
Despite well known complications, oral nonsteroidal anti-inflammatory drugs (NSAIDs) remain the most commonly prescribed medications in the US for musculoskeletal disorders such as osteoarthritis. Although there has been a recent focus on the cardiovascular and renal complications associated with these agents, NSAID gastropathy continues to be a particular concern in many patients, especially those at increased risk for serious adverse events, including the elderly. Complicating the diagnosis of NSAID gastropathy is its silent course, which, up to half of the time, is asymptomatic. Several strategies are currently employed by physicians to mitigate the risk of serious gastrointestinal events. These include either addition of a proton pump inhibitor to current nonselective NSAID therapy or the use of a cyclo-oxygenase-2-selective NSAID. Although these agents are effective at mitigating the overall risk of gastrointestinal adverse events, they fail to address NSAID-related cardiovascular and renal risks. Due to their reduced systemic absorption, topical NSAIDs may present a viable option for patients at increased risk for serious NSAID-related adverse events, including gastropathy.

S22564131
Paediatric obsessive-compulsive disorder (OCD) is a common, yet under-recognized, neuropsychiatric illness in both clinical and community settings. Symptoms tend to be hidden or misunderstood by affected youth, and parents may inadvertently accommodate OCD, thus worsening its severity. These symptoms may include compulsive reassurance seeking, confessing and 'just right' rituals, in addition to more classic OCD behaviours. Fortunately, numerous psychometric measures are available to assist in clinical assessment of this disorder and its sequelae. Once properly diagnosed, paediatric OCD is highly treatable with empirically proven approaches including cognitive-behaviour therapy (CBT) and serotonin reuptake inhibitor (SRI) medications. Clinically meaningful symptom improvement is the norm following these strategies, although full remission is not, as symptoms tend to wax and wane over time. Paediatric OCD is highly co-morbid with other anxiety disorders, tic disorders, depression and attention-deficit hyperactivity disorder, which also require specific attention. For moderate to severe OCD, an interdisciplinary approach combining individual and family CBT with SRI trials is recommended. For severe treatment-refractory illness, early evidence supports the benefit of augmenting agents, such as atypical antipsychotics and potentially those with glutamatergic activity. Clinical outcome assessment in paediatric OCD should always include broad domains of individual and family functioning, in addition to symptom improvement.

 

EUROPEAN HEART JOURNAL

 

S22408036
Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the population worldwide and may confer increased cardiometabolic risk with consequent adverse cardiovascular outcomes independent of traditional cardiovascular risk factors and the metabolic syndrome. It is characterized almost universally by insulin resistance and is strongly associated with type 2 diabetes and obesity. Non-alcoholic fatty liver disease is a marker of pathological ectopic fat accumulation combined with a low-grade chronic inflammatory state. This results in several deleterious pathophysiological processes including abnormal glucose, fatty acid and lipoprotein metabolism, increased oxidative stress, deranged adipokine profile, hypercoaguability, endothelial dysfunction, and accelerated progression of atherosclerosis. This ultimately leads to a dysfunctional cardiometabolic phenotype with cardiovascular mortality representing the main mode of premature death in NAFLD. This review is aimed at introducing NAFLD to the clinical cardiologist by discussing in-depth the evidence to date linking NAFLD with cardiovascular disease, reviewing the likely mechanisms underlying this association, as well as summarizing from a cardiologist's perspective, current and potential future treatment options for this increasingly prevalent disease

S22507981

Evidence assembled in this review indicates that sympathetic nervous system dysfunction is crucial in the development of heart failure and essential hypertension. This takes the form of persistent and adverse activation of sympathetic outflows to the heart and kidneys in both conditions. An important goal for clinical scientists is translation of the knowledge of pathophysiology, such as this, into better treatment for patients. The achievement of this 'mechanisms to management' transition is at different stages of development with regard to the two disorders. Clinical translation is mature in cardiac failure, knowledge of cardiac neural pathophysiology having led to the introduction of beta-adrenergic blockers, an effective therapy. With essential hypertension perhaps we are on the cusp of effective translation, with recent successful testing of selective catheter-based renal sympathetic nerve ablation in patients with resistant hypertension, an intervention firmly based on the demonstration of activation of the renal sympathetic outflow. Additional evidence in this regard is provided by the results of pilot studies exploring the possibility to reduce blood pressure in resistant hypertensives through electrical stimulation of the area of carotid baroreceptors. Despite the general importance of the sympathetic nervous system in blood pressure regulation, and the specific demonstration that the blood pressure elevation in essential hypertension is commonly initiated and sustained by sympathetic nervous activation, drugs antagonizing this system are currently underutilized in the care of patients with hypertension. Use of beta-adrenergic blocking drugs is waning, given the propensity of this drug class to have adverse metabolic effects, including predisposition to diabetes development. The blood pressure lowering achieved with carotid baroreceptor stimulation and with the renal denervation device affirms the importance of the sympathetic nervous system in hypertension pathogenesis, and perhaps suggests a wider role for anti-adrenergic antihypertensives, such as the imidazoline drug class (moxonidine, rilmenidine) which act within the CNS to inhibit central sympathetic outflow, although the lack of large-scale outcome trials with this drug class remains a very material deficiency.

S22408030

This raises the question of whether the Cardiological community dismissed digoxin too readily and if we should reappraise its potential role in the treatment of heart failure

 

FAMILY MEDICINE

 

Accepting gifts from the pharmaceutical industry has implications for the doctor-patient relationship. Doing so can undermine trust and affect patients’ intent to adhere to medical

recommendations.

 

An intervention using a learning coach to provide one-on-one EBM and information mastery instruction to residents improved residents’ attitudes, knowledge, and use of both in the clinical setting.

 

Internet use was high among our primary care patients. The major factor associated with Internet use among patients with chronic conditions was their age. If older adults with chronic illness are to reap the benefits of health information technology, their Internet access will need to be improved. Institutions that are planning to offer consumer health information technology should be aware of groups with lower Internet access.

 

GUT

 

S22491499
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

 

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE

 

S22570392
Comprehensive primary care mental health screening that considers both anxiety and depression while including strength-based and psychosocial support questions is a helpful adjunct to clinical practices and has been done routinely by using an electronic tool at the point of care. Because certain common somatic and emotional concerns can precede depression and anxiety, routine screening for these issues along with depression and anxiety screening is suggested.

S22570399
Family physicians play a crucial role in the management and ongoing care of patients with Alzheimer disease (AD). This article reviews the effects of nonpharmacologic and pharmacologic interventions on the functional abilities and behavior of patients with dementia and how these can be implemented into clinical practice. Nonpharmacologic interventions are recommended as the initial strategy for managing problematic behaviors. Strategies for improving behavior include ensuring that the patient's environment is safe, calm, and predictable; removing environmental stressors; and identifying and avoiding situations that agitate or frighten the patient. Simple interventions include redirecting and refocusing the patient, increasing social interaction, establishing regular sleep habits, eliminating sources of conflict and frustration, and establishing rewards for successes. The effectiveness of long-term behavioral management is largely dependent on the caregiver; as such, it is important to assess the role and needs of the caregiver. Because currently available therapies cannot reverse the pathologic processes of AD, the primary objective of pharmacotherapy is to preserve cognitive and functional ability, minimize behavioral disturbances, and slow disease progression. Cholinesterase inhibitors represent first-line therapy for patients with mild to moderate AD, whereas a glutamate N-methyl D-aspartate antagonist is used in the treatment of moderate to severe AD. Looking forward, there are a number of therapies in development aimed at modifying the disease course; these include amyloid-lowering drugs, t-based and neuroprotective approaches, acetylcholine agonists, and mitochondrial inhibitors.

S22570400
To date, user-friendly, practical guidelines for dementia have not been available for busy family physicians. However, the growing number of patients with dementia means that primary care physicians will have an increasingly important role in the diagnosis and subsequent management of dementia. This article provides practical guidance for the recognition and diagnosis of dementia and is aimed at family physicians, who are usually the first clinicians to whom patients present with dementia symptoms. Because Alzheimer disease (AD) is the most common form of dementia, this condition is the main focus of this article. We review the pathophysiology of AD and discuss recommended diagnostic protocols and the importance of early diagnosis. An AD diagnostic algorithm is provided, with clearly defined steps for screening and diagnosing AD and assessing daily functioning, behavioral symptoms, and caregiver status.

 

MEDICINA CLINICA

 

S22397982
La anemia supone un mayor riesgo de mortalidad por IC refractaria, pero no de reingreso, en el primer año tras una descompensación aguda.

S22503128
En el presente documento se pretende adaptar las recomendaciones generales establecidas en un consenso para la elaboración del informe de alta hospitalaria en especialidades médicas a las necesidades específicas de la población diabética hospitalizada. La diabetes es una enfermedad con un coste sanitario muy elevado, siendo el riesgo global de muerte entre personas con diabetes casi el doble que entre personas sin diabetes, lo que justifica que esta patología constituya uno de los diagnósticos más frecuentes en los pacientes hospitalizados y el creciente interés sobre el tratamiento de la hiperglucemia durante la hospitalización y al alta. Para establecer un plan de tratamiento al alta adecuado a cada paciente, los elementos más importantes a tener en cuenta son la etiología y el tratamiento previo de la hiperglucemia, la situación clínica del paciente y el grado de control glucémico. Debido a la inestabilidad del control glucémico también es necesario prever las necesidades educativas de cada paciente, así como establecer las pautas de monitorización y seguimiento al alta, y un adecuado plan de tratamiento al alta.

S22015005
Se realizó una revisión sistemática de artículos científicos y estudios de instituciones oficiales europeas. En total, fueron identificados 21 artículos y 10 estudios. Los datos sugieren un aumento de la iniciación sexual juvenil y del número de parejas sexuales. El 15-20% de los jóvenes usan de forma inconstante el preservativo. Entre los conocimientos y actitudes de riesgo detectadas encontramos: desconocer otras ITS distintas al VIH, tener una actitud favorable a las relaciones sexuales casuales, creer erróneamente que algunas medidas son eficaces para prevenir el VIH, desconocer los riesgos de tener múltiples parejas sexuales y desconocer la transmisión sexual del VIH.

S21663923
Tras el diagnóstico inicial de la IC, más de la mitad de los pacientes fallecen a los 10 años de seguimiento. La edad, la diabetes mellitus, la cardiopatía isquémica y la insuficiencia renal crónica se asocian a un peor pronóstico en estos pacientes, mientras que el uso de betabloqueantes se asocia a un mejor pronóstico.

S22118974
Se constata el deterioro del control glucémico con la evolución de la enfermedad y la complejidad del proceso y del tratamiento, lo que en parte puede estar relacionado con la inadecuada selección e intensificación del tratamiento.

S22153783
La implantación del CI es un sistema que mejoró la atención precoz del ictus en todo el territorio, pero su activación en el ámbito de atención primaria fue baja.

S22440145
Use of AOBP devices can contribute to decrease WCE and to improve accuracy of office BP measurement.

S21944650
Más de 5 de cada 10 mujeres hipertensas mayores de 64 años presentan ERC, y de estas casi la mitad tienen valores de creatinina normales.

 

 

REUMATOLOGIA CLINICA

 

S22089065
En la actualidad, la determinación de marcadores bioquímicos de remodelado óseo supone una propuesta novedosa en la evaluación clínica de los pacientes con osteoporosis. El uso de estos biomarcadores podría permitir la identificación de pacientes con mayor riesgo de fractura y monitorizar la respuesta terapéutica. Al tratarse de mediciones no invasivas y relativamente económicas, debería extenderse su empleo, ya que posibilitaría una medición seriada y en intervalos cortos de las variaciones en el recambio óseo. Sin embargo, su variabilidad analítica y biológica limita en la actualidad su aplicabilidad clínica.

S22421456
La prevención de FC con alendronato en mujeres osteoporóticas > 64 años es coste-útil a largo plazo (20 años) con bajo impacto presupuestario en el grupo de 75-79 años.

 

THE LANCET

 

S22538178
Adolescence is a life phase in which the opportunities for health are great and future patterns of adult health are established.

Health in adolescence is the result of interactions between prenatal and early childhood development and the specific biological and social-role changes that accompany puberty, shaped by social determinants and risk and protective factors that affect the uptake of health-related behaviours. The shape of adolescence is rapidly changing-the age of onset of puberty is decreasing and the age at which mature social roles are achieved is rising. New understandings of the diverse and dynamic effects on adolescent health include insights into the effects of puberty and brain development, together with social media. A focus on adolescence is central to the success of many public health agendas, including the Millennium Development Goals aiming to reduce child and maternal mortality and HIV/AIDS, and the more recent emphases on mental health, injuries, and non-communicable diseases. Greater attention to adolescence is needed within each of these public health domains if global health targets are to be met. Strategies that place the adolescent years centre stage-rather than focusing only on specific health agendas-provide important opportunities to improve health, both in adolescence and later in life.

S22538179
The health of adolescents is strongly affected by social factors at personal, family, community, and national levels. Nations present young people with structures of opportunity as they grow up. Since health and health behaviours correspond strongly from adolescence into adult life, the way that these social determinants affect adolescent health are crucial to the health of the whole population and the economic development of nations. During adolescence, developmental effects related to puberty and brain development lead to new sets of behaviours and capacities that enable transitions in family, peer, and educational domains, and in health behaviours.

These transitions modify childhood trajectories towards health and wellbeing and are modified by economic and social factors within countries, leading to inequalities. We review existing data on the effects of social determinants on health in adolescence, and present findings from country-level ecological analyses on the health of young people aged 10-24 years. The strongest determinants of adolescent health worldwide are structural factors such as national wealth, income inequality, and access to education. Furthermore, safe and supportive families, safe and supportive schools, together with positive and supportive peers are crucial to helping young people develop to their full potential and attain the best health in the transition to adulthood. Improving adolescent health worldwide requires improving young people's daily life with families and peers and in schools, addressing risk and protective factors in the social environment at a population level, and focusing on factors that are protective across various health outcomes. The most effective interventions are probably structural changes to improve access to education and employment for young people and to reduce the risk of transport-related injury.

S22475493
Cervical pessary use could prevent preterm birth in a population of appropriately selected at-risk women previously screened for cervical length assessment at the midtrimester scan.

S22440946
Alongside the previously reported reduction by aspirin of the long-term risk of cancer death, the short-term reductions in cancer incidence and mortality and the decrease in risk of major extracranial bleeds with extended use, and their low case-fatality, add to the case for daily aspirin in prevention of cancer.

S22440947
That aspirin prevents distant metastasis could account for the early reduction in cancer deaths in trials of daily aspirin versus control. This finding suggests that aspirin might help in treatment of some cancers and provides proof of principle for pharmacological intervention specifically to prevent distant metastasis.

S22559900
Myopia has emerged as a major health issue in east Asia, because of its increasingly high prevalence in the past few decades (now 80-90% in school-leavers), and because of the sight-threatening pathologies associated with high myopia, which now affects 10-20% of those completing secondary schooling in this part of the world. Similar, but less marked, changes are occurring in other parts of the world. The higher prevalence of myopia in east Asian cities seems to be associated with increasing educational pressures, combined with life-style changes, which have reduced the time children spend outside. There are no reported major genes for school myopia, although there are several genes associated with high myopia. Any genetic contribution to ethnic differences may be small. However, to what extent many genes of small effect and gene-environment interactions contribute to variations in school myopia within populations remains to be established. There are promising optical and pharmacological interventions for preventing the development of myopia or slowing its progression, which require further validation, and promising vision-sparing treatments for pathological myopia.

S22377290

Adults with disabilities are at a higher risk of violence than are non-disabled adults, and those with mental illnesses could be particularly vulnerable. However, available studies have methodological weaknesses and gaps exist in the types of disability and violence they address. Robust studies are absent for most regions of the world, particularly low-income and middle-income countries.

S22377290
Adults with disabilities are at a higher risk of violence than are non-disabled adults, and those with mental illnesses could be particularly vulnerable. However, available studies have methodological weaknesses and gaps exist in the types of disability and violence they address. Robust studies are absent for most regions of the world, particularly low-income and middle-income countries.

S22538180
The burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelerating in low-income and middle-income countries, whereas the burden from infectious diseases has declined. Since this transition, the prevention of non-communicable disease as well as communicable disease causes of adolescent mortality has risen in importance. Problem behaviours that increase the short-term or long-term likelihood of morbidity and mortality, including alcohol, tobacco, and other drug misuse, mental health problems, unsafe sex, risky and unsafe driving, and violence are largely preventable. In the past 30 years new discoveries have led to prevention science being established as a discipline designed to mitigate these problem behaviours. Longitudinal studies have provided an understanding of risk and protective factors across the life course for many of these problem behaviours. Risks cluster across development to produce early accumulation of risk in childhood and more pervasive risk in adolescence. This understanding has led to the construction of developmentally appropriate prevention policies and programmes that have shown short-term and long-term reductions in these adolescent problem behaviours. We describe the principles of prevention science, provide examples of efficacious preventive interventions, describe challenges and potential solutions to take efficacious prevention policies and programmes to scale, and conclude with recommendations to reduce the burden of adolescent mortality and morbidity worldwide through preventive intervention.

 

 

THE NEW ENGLAND JOURNAL OF MEDICINE

 

S22591295
In this large prospective study, coffee consumption was inversely associated with total and cause-specific mortality. Whether this was a causal or associational finding cannot be determined from our data.

S22591294
During 5 days of azithromycin therapy, there was a small absolute increase in cardiovascular deaths, which was most pronounced among patients with a high baseline risk of cardiovascular disease

S22621626
Aspirin reduced the risk of recurrence when given to patients with unprovoked venous thromboembolism who had discontinued anticoagulant treatment, with no apparent increase in the risk of major bleeding.

 

THORAX

 

S22052579
This is encouraging early evidence that an awareness and early recognition initiative may facilitate lung cancer diagnosis.

 

 

 

                      

XXVIII Congreso de Comunicación y Salud

 

 

semFYC - JRT 2017

 

Cáceres, 10 y 11 de Noviembre 2017


____________________________

 Para pacientes
@pontealdiaAP
 @pontealdiaURG
55 e.SAMFyC

 


 

semFYC
 

 

Estadisticas

Ver contenido por hits : 1098931



La SAMFyC:
 C/ Arriola, 4, bajo D, CP.18001 - Granada. Email: samfyc@samfyc.es; Teléfono: 958 804 201 - Fax: 958 804 202. Horario de invierno: lunes a jueves de 9:00 a 17:30 horas; viernes de 9:00 a 14:30 horas. Horario de verano: lunes a viernes de 8:00 a 15:00h. Todos los derechos reservados. Aviso Legal. 


¡CSS Válido!

Diseño web